| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
9,287 |
7,840 |
$346K |
| 96401 |
|
8,916 |
5,450 |
$342K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
409 |
392 |
$34K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,363 |
1,397 |
$21K |
| 20605 |
|
446 |
422 |
$11K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
75 |
74 |
$8K |
| J9250 |
Methotrexate sodium, 5 mg |
8,386 |
5,035 |
$7K |
| 73120 |
|
368 |
185 |
$7K |
| 99245 |
|
47 |
47 |
$7K |
| 73620 |
|
173 |
87 |
$3K |
| 73565 |
|
138 |
138 |
$3K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
591 |
549 |
$3K |
| 73030 |
|
126 |
63 |
$2K |
| 20610 |
|
53 |
51 |
$2K |
| J9255 |
Injection, methotrexate (accord), not therapeutically equivalent to j9260, 50 mg |
739 |
448 |
$1K |
| J9260 |
Injection, methotrexate sodium, 50 mg |
38 |
35 |
$15.22 |
| J0135 |
Injection, adalimumab, 20 mg |
1,132 |
632 |
$2.00 |